The efficacy of intravesical bacillus Calmette-Guerin in the treatment of interstitial cystitis: long-term followup

The Journal of Urology
K PetersJ A Gonzalez

Abstract

Interstitial cystitis is a severe debilitating bladder disease characterized by unrelenting pelvic pain and urinary frequency. A prospective, double-blind, placebo controlled study of the use of intravesical bacillus Calmette-Guerin (BCG) in the treatment of interstitial cystitis was recently completed with a mean followup of 8 months. Results demonstrated a 60% BCG response rate, compared to a 27% placebo response rate. We now report the long-term followup results of those patients who received intravesical BCG. Subjects randomized to receive BCG were followed at routine intervals with questionnaires and voiding diaries identical to those in the blinded study. Adverse events were closely monitored in the treatment and followup phases of the study. Subject baseline values were compared to followup data. Of the BCG responders mean followup was 27 months (range 24 to 33), and 8 of 9 (89%) continue to have an excellent response in all parameters measured. The global interstitial cystitis survey improved 70%, daily voids decreased 31%, nocturia improved 54%, mean voided volume increased 61%, pelvic pain decreased 81%, vaginal pain decreased 71%, urgency decreased 71% and dysuria decreased 82%. Overall well-being improved 54% and th...Continue Reading

References

Mar 1, 1992·Clinical and Experimental Immunology·T J Christmas, G F Bottazzo
Mar 1, 1991·Immunology Today·T R Mosmann, K W Moore
Jul 1, 1989·The Journal of Urology·G E Striker
Mar 1, 1970·The Journal of Urology·M R Silk
Feb 1, 1995·International Journal of Immunopharmacology·G A Rook, J L Stanford
May 1, 1994·British Journal of Urology·C L ParsonsD Lebow
Sep 1, 1994·The Journal of Urology·M LotzB L Zuraw
Mar 1, 1993·The Journal of Urology·M LiebertH B Grossman
Jun 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R KaempferA Shapiro
Mar 1, 1997·The Journal of Urology·S KeayJ W Warren
Oct 8, 1997·Clinics in Laboratory Medicine·R L Ochs

❮ Previous
Next ❯

Citations

Jan 25, 2012·International Urogynecology Journal·Tilemachos KavvadiasBernhard Schuessler
Mar 17, 2001·Current Pain and Headache Reports·T J Ness
Jun 27, 2002·Current Urology Reports·A E GousseS Madjar
Mar 12, 2004·Urology·Michael B Chancellor, Naoki Yoshimura
Mar 15, 2003·Obstetrics and Gynecology·Fred M Howard
Dec 13, 2002·The Urologic Clinics of North America·James Chivian LukbanGrannum R Sant
Feb 14, 2006·Nature Clinical Practice. Urology·Sagar Phatak, Harris E Foster
Sep 24, 1999·Journal of Women's Health & Gender-based Medicine·D R Erickson
Dec 9, 2000·Current Opinion in Obstetrics & Gynecology·A RosamiliaP L Dwyera
Feb 28, 2002·Clinical Obstetrics and Gynecology·Robert M Moldwin, Grannum R Sant
Mar 11, 2005·The Journal of Urology·Robert MayerUNKNOWN Interstitial Cystitis Clinical Trials Group
Feb 16, 2005·The Journal of Urology·Erenee SirinianChristopher K Payne
Apr 23, 2004·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·J C LukbanK E Whitmore
Sep 17, 2011·European Urology·Antonella GiannantoniJean Jacques Wyndaele
Dec 18, 2007·The Journal of Urology·Kathleen Joy PropertUNKNOWN Interstitial Cystitis Clinical Trials Group
Mar 27, 2015·Journal of Evaluation in Clinical Practice·Maria Beatriz F GurianFrancisco José Candido dos Reis
Nov 5, 2003·Expert Opinion on Pharmacotherapy·James Chivian Lukban
Mar 31, 2004·The Medical Clinics of North America·J Curtis Nickel
Sep 7, 2017·Expert Opinion on Biological Therapy·Ioannis MykoniatisVladimir Yutkin
Jan 2, 2007·Current Opinion in Infectious Diseases·Robert Mayer
Jun 25, 2009·International Journal of Urology : Official Journal of the Japanese Urological Association·Yukio HommaUNKNOWN Interstitial cystitis guideline committee
Jan 6, 2009·International Journal of Urology : Official Journal of the Japanese Urological Association·Yukio HommaHikaru Tomoe
Jun 20, 2002·Current Opinion in Urology·Frank OberpenningLothar Hertle
Oct 19, 2007·The Cochrane Database of Systematic Reviews·T E Dawson, J Jamison
Aug 1, 2020·The Cochrane Database of Systematic Reviews·Mari ImamuraMiriam Brazzelli
Jul 21, 2005·Scandinavian Journal of Urology and Nephrology·Else B KallestrupTage Hald
Dec 26, 2001·Current Opinion in Urology·John W Warren, Susan K Keay
Aug 25, 1999·Current Opinion in Urology·G R Sant, T C Theoharides
May 31, 2003·Scandinavian Journal of Urology and Nephrology·O O Ajibona, E O Kehinde
Feb 9, 2012·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Monika VijLinda Cardozo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.